Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana-Maria Singeap

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
Life (Basel, Switzerland)|August 28, 2025
Advancements in Beta-Adrenergic Therapy and Novel Personalised Approach for Portal Hypertension: A Narrative ReviewRaluca-Ioana Avram, Horia Octav Minea, Laura Huiban, et al.
Diagnostics (Basel, Switzerland)|July 27, 2022
Simultaneously Screening for Liver Steatosis and Fibrosis in Romanian Type 2 Diabetes Mellitus Patients Using Vibration-Controlled Transient Elastography with Controlled Attenuation ParameterAnca Trifan, Ermina Stratina, Robert Nastasa, et al.
Life (Basel, Switzerland)|February 26, 2025
Lean MASLD and IBD: Exploring the Intersection of Metabolic Dysfunction and the Gut-Liver AxisAdrian Rotaru, Remus Stafie, Ermina Stratina, et al.
Diagnostics (Basel, Switzerland)|March 25, 2022
Changes in Liver Steatosis Using Controlled Attenuation Parameter among Patients with Chronic Hepatitis C Infection Treated with Direct-Acting Antivirals Therapy Who Achieved Sustained Virological ResponseAnca Trifan, Ermina Stratina, Adrian Rotaru, et al.
Hepatology Communications|January 24, 2023
High prevalence of liver fibrosis among general population: a Romanian population-based studyAnca Trifan, Cristina-Maria Muzica, Robert Nastasa, et al.
Medicina (Kaunas, Lithuania)|December 23, 2022
Predictive Factors for the Prognosis of Alcoholic Liver CirrhosisAnca Trifan, Horia Minea, Adrian Rotaru, et al.
Journal of Clinical Medicine|October 14, 2022
Screening for Liver Steatosis and Fibrosis in Patients with Inflammatory Bowel Disease Using Vibration Controlled Transient Elastography with Controlled Attenuation ParameterAnca Trifan, Remus Stafie, Adrian Rotaru, et al.
Life (Basel, Switzerland)|February 25, 2023
Changes in Components of Metabolic Syndrome after Antiviral Eradication in Hepatitis C Virus InfectionAnca Trifan, Tudor Cuciureanu, Robert Nastasa, et al.
Medicina (Kaunas, Lithuania)|September 28, 2024
Impact of Treatment with Direct Antivirals on Coagulation Parameters in Patients with Hepatitis C Virus-Related Liver Cirrhosis and Sustained Virological ResponseLaura Huiban, Carol Stanciu, Cristina Maria Muzica, et al.
Diagnostics (Basel, Switzerland)|July 27, 2024
New Insights on Using Oral Semaglutide versus Dapagliflozin in Patients with Type 2 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver DiseaseErmina Stratina, Carol Stanciu, Robert Nastasa, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Life (Basel, Switzerland)|August 28, 2025
Advancements in Beta-Adrenergic Therapy and Novel Personalised Approach for Portal Hypertension: A Narrative ReviewRaluca-Ioana Avram, Horia Octav Minea, Laura Huiban, et al.
Diagnostics (Basel, Switzerland)|July 27, 2022
Simultaneously Screening for Liver Steatosis and Fibrosis in Romanian Type 2 Diabetes Mellitus Patients Using Vibration-Controlled Transient Elastography with Controlled Attenuation ParameterAnca Trifan, Ermina Stratina, Robert Nastasa, et al.
Life (Basel, Switzerland)|February 26, 2025
Lean MASLD and IBD: Exploring the Intersection of Metabolic Dysfunction and the Gut-Liver AxisAdrian Rotaru, Remus Stafie, Ermina Stratina, et al.
Diagnostics (Basel, Switzerland)|March 25, 2022
Changes in Liver Steatosis Using Controlled Attenuation Parameter among Patients with Chronic Hepatitis C Infection Treated with Direct-Acting Antivirals Therapy Who Achieved Sustained Virological ResponseAnca Trifan, Ermina Stratina, Adrian Rotaru, et al.
Hepatology Communications|January 24, 2023
High prevalence of liver fibrosis among general population: a Romanian population-based studyAnca Trifan, Cristina-Maria Muzica, Robert Nastasa, et al.
Medicina (Kaunas, Lithuania)|December 23, 2022
Predictive Factors for the Prognosis of Alcoholic Liver CirrhosisAnca Trifan, Horia Minea, Adrian Rotaru, et al.
Journal of Clinical Medicine|October 14, 2022
Screening for Liver Steatosis and Fibrosis in Patients with Inflammatory Bowel Disease Using Vibration Controlled Transient Elastography with Controlled Attenuation ParameterAnca Trifan, Remus Stafie, Adrian Rotaru, et al.
Life (Basel, Switzerland)|February 25, 2023
Changes in Components of Metabolic Syndrome after Antiviral Eradication in Hepatitis C Virus InfectionAnca Trifan, Tudor Cuciureanu, Robert Nastasa, et al.
Medicina (Kaunas, Lithuania)|September 28, 2024
Impact of Treatment with Direct Antivirals on Coagulation Parameters in Patients with Hepatitis C Virus-Related Liver Cirrhosis and Sustained Virological ResponseLaura Huiban, Carol Stanciu, Cristina Maria Muzica, et al.
Diagnostics (Basel, Switzerland)|July 27, 2024
New Insights on Using Oral Semaglutide versus Dapagliflozin in Patients with Type 2 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver DiseaseErmina Stratina, Carol Stanciu, Robert Nastasa, et al.
Pageof 7